Ting Shi1, Yujing Ooi1, Ei Mon Zaw1, Natasa Utjesanovic1, Harry Campbell1, Steve Cunningham2,3, Louis Bont4,5, Harish Nair1,5. 1. Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics. 2. Centre for Inflammation Research, University of Edinburgh. 3. Royal Hospital for Sick Children, Edinburgh, United Kingdom. 4. Department of Pediatric Infectious Diseases and Immunology, University Medical Center Utrecht. 5. Respiratory Syncytial Virus Network Foundation, Zeist, The Netherlands.
Abstract
BACKGROUND: Recurrent wheeze and asthma in childhood are commons causes of chronic respiratory morbidity globally. We aimed to explore the association between respiratory syncytial virus (RSV) infection in early life and subsequent respiratory sequelae up to age 12 years. METHODS: We estimated the strength of association by 3 control groups and 3 follow-up age groups, with data from studies published between January 1995 and May 2018. We also estimated associations by diagnostic criteria, age at infection, and high-risk population. RESULTS: Overall, we included 41 studies. A statistically significant association was observed between early life RSV infection and subsequent childhood recurrent wheeze, in comparison to those who were healthy or those without respiratory symptoms: OR 3.05 (95% confidence interval [CI], 2.50-3.71) for 0 to <36 months follow-up age; OR 2.60 (95% CI, 1.67-4.04) for 36-72 months; and OR 2.14 (95% CI, 1.33-3.45) for 73-144 months. For the subsequent development of asthma, a statistically significant association was observed only in relation to those aged 73-144 months at follow-up: OR 2.95 (95% CI, 1.96-4.46). CONCLUSIONS: Further studies using standardized definitions and from diverse settings are needed to elucidate the role of confounders and provide more robust estimates.
BACKGROUND: Recurrent wheeze and asthma in childhood are commons causes of chronic respiratory morbidity globally. We aimed to explore the association between respiratory syncytial virus (RSV) infection in early life and subsequent respiratory sequelae up to age 12 years. METHODS: We estimated the strength of association by 3 control groups and 3 follow-up age groups, with data from studies published between January 1995 and May 2018. We also estimated associations by diagnostic criteria, age at infection, and high-risk population. RESULTS: Overall, we included 41 studies. A statistically significant association was observed between early life RSV infection and subsequent childhood recurrent wheeze, in comparison to those who were healthy or those without respiratory symptoms: OR 3.05 (95% confidence interval [CI], 2.50-3.71) for 0 to <36 months follow-up age; OR 2.60 (95% CI, 1.67-4.04) for 36-72 months; and OR 2.14 (95% CI, 1.33-3.45) for 73-144 months. For the subsequent development of asthma, a statistically significant association was observed only in relation to those aged 73-144 months at follow-up: OR 2.95 (95% CI, 1.96-4.46). CONCLUSIONS: Further studies using standardized definitions and from diverse settings are needed to elucidate the role of confounders and provide more robust estimates.
Authors: Mohammad Shahidul Islam; Samin Huq; Steven Cunningham; Jurgen Schwarze; A S M D Ashraful Islam; Mashal Amin; Farrukh Raza; Radanath Satpathy; Pradipta Ranjan Rauta; Salahuddin Ahmed; Hana Mahmood; Genevie Fernandes; Benazir Baloch; Imran Nisar; Sajid Soofi; Pinaki Panigrahi; Sanjay Juvekar; Ashish Bavkedar; Abdullah H Baqui; Senjuti Saha; Harry Campbell; Aziz Sheikh; Harish Nair; Samir K Saha Journal: Ther Adv Infect Dis Date: 2022-07-18
Authors: Sandra Axberg Pålsson; Aleksandra Dondalska; Joseph Bergenstråhle; Caroline Rolfes; Albin Björk; Laura Sedano; Ultan F Power; Marie-Anne Rameix-Welti; Joakim Lundeberg; Marie Wahren-Herlenius; Peter Mastrangelo; Jean-Francois Eleouet; Ronan Le Goffic; Marie Galloux; Anna-Lena Spetz Journal: Front Immunol Date: 2020-12-08 Impact factor: 7.561
Authors: Mythili Srinivasan; Leonard B Bacharier; Charles W Goss; Yanjiao Zhou; Jonathan Boomer; Sarah Bram; Dana Burgdorf; Carey-Ann Burnham; Timothy Casper; Mario Castro; Andrea Coverstone; Matthew Haslam; Watcharoot Kanchongkittiphon; Cadence Kuklinski; Qinghua Lian; Kenneth Schechtman; Gregory A Storch; Kelly True; Meghan A Wallace; Huiqing Yin-DeClue; Elizabeth Ahrens; Jinli Wang; Avraham Beigelman Journal: Contemp Clin Trials Commun Date: 2021-06-09
Authors: Steven M Brunwasser; Brittney M Snyder; Amanda J Driscoll; Deshayne B Fell; David A Savitz; Daniel R Feikin; Becky Skidmore; Niranjan Bhat; Louis J Bont; William D Dupont; Pingsheng Wu; Tebeb Gebretsadik; Patrick G Holt; Heather J Zar; Justin R Ortiz; Tina V Hartert Journal: Lancet Respir Med Date: 2020-08 Impact factor: 30.700
Authors: Amanda J Driscoll; S Hasan Arshad; Louis Bont; Steven M Brunwasser; Thomas Cherian; Janet A Englund; Deshayne B Fell; Laura L Hammitt; Tina V Hartert; Bruce L Innis; Ruth A Karron; Gayle E Langley; E Kim Mulholland; Patrick K Munywoki; Harish Nair; Justin R Ortiz; David A Savitz; Nienke M Scheltema; Eric A F Simões; Peter G Smith; Fred Were; Heather J Zar; Daniel R Feikin Journal: Vaccine Date: 2020-01-20 Impact factor: 3.641
Authors: Heather J Zar; Polite Nduru; Jacob A M Stadler; Diane Gray; Whitney Barnett; Maia Lesosky; Landon Myer; Mark P Nicol Journal: Lancet Glob Health Date: 2020-10 Impact factor: 38.927